May 15th 2024
The federal agency gave the nod to Roche’s human papillomavirus (HPV) self-collection and gives women the ability to gather their own sample in a health care setting, which can then be sent off for lab results.
PrEP: Estimating the Cost-Effectiveness Over 40 Years
March 12th 2019Short-term investments in pre-exposure prophylaxis (PrEP) are predicted to result in long-term cost-savings and promote significant health benefits following its distribution in Germany, according to a new modelling study in Eurosurveillance.
Read More
Tuberculosis Raises Mortality Risk in HIV Infected, Even After Successful TB Treatment
March 11th 2019A new study examining tuberculosis and HIV coinfection in patients in Latin America has found that those with TB had higher mortality rates over the course of a decade, despite successful TB treatment.
Read More
ATLAS: Long-Acting Cabotegravir + Rilpivirine Non-Inferior to Oral ART at 48 Weeks
March 7th 2019The ATLAS trial evaluated whether a switch to monthly long-acting injectable cabotegravir/rilpivirine is non-inferior to continued 3-drug oral antiretroviral therapy in virologically suppressed adults.
Read More